Skip to main content
Microbial Genomics logoLink to Microbial Genomics
. 2020 Mar 11;6(4):e000353. doi: 10.1099/mgen.0.000353

Origin, maintenance and spread of antibiotic resistance genes within plasmids and chromosomes of bloodstream isolates of Escherichia coli

Cosmika Goswami 1, Stephen Fox 1, Matthew TG Holden 2, Martin Connor 3, Alistair Leanord 1, Thomas J Evans 1,*
PMCID: PMC7276700  PMID: 32160146

Abstract

Blood stream invasion by Escherichia coli is the commonest cause of bacteremia in the UK and elsewhere with an attributable mortality of about 15–20 %; antibiotic resistance to multiple agents is common in this microbe and is associated with worse outcomes. Genes conferring antimicrobial resistance, and their frequent location on horizontally transferred genetic elements is well-recognised, but the origin of these determinants, and their ability to be maintained and spread within clinically-relevant bacterial populations is unclear. Here, we set out to examine the distribution of antimicrobial resistance genes in chromosomes and plasmids of 16 bloodstream isolates of E. coli from patients within Scotland, and how these genes are maintained and spread. Using a combination of short and long-read whole genome sequencing methods, we were able to assemble complete sequences of 44 plasmids, with 16 Inc group F and 20 col plasmids; antibiotic resistance genes located almost exclusively within the F group. bla CTX-M15 genes had re-arranged in some strains into the chromosome alone (five strains), while others contained plasmid copies alone (two strains). Integrons containing multiple antibiotic genes were widespread in plasmids, notably many with a dfrA7 gene encoding resistance to trimethoprim, thus linking trimethoprim resistance to the other antibiotic resistance genes within the plasmids. This will allow even narrow spectrum antibiotics such as trimethoprim to act as a selective agent for plasmids containing antibiotic resistance genes mediating much broader resistance, including blaCTX-M15. To our knowledge, this is the first analysis to provide complete sequence data of chromosomes and plasmids in a collection of pathogenic human bloodstream isolates of E. coli . Our findings reveal the interplay between plasmids and integrative and conjugative elements in the maintenance and spread of antibiotic resistance genes within pathogenic E. coli .

Keywords: bacteremia, extended spectrum beta-lactamases, horizontal gene transfer

Data Summary

All genome data for this study have been deposited in European Nucleotide Archive (ENA). Short-read Illumina sequences were deposited under accession PRJEB12513. The raw FAST5 PacBio sequences and Unicycler assemblies were submitted under the project accession PRJEB33761. The global ST69 isolates with their accession details are in Table S1, (available in the online version of this article).

Impact Statement.

Autonomously replicating plasmids are important elements determining bacterial resistance to a number of antimicrobial agents. Understanding the origin of these elements, and how they are maintained and spread, is thus crucial in tackling the alarming rise in bacterial antimicrobial resistance. In this paper, we have fully sequenced chromosomes and plasmids from bloodstream isolates of Escherichia coli , the commonest cause of bloodstream infection worldwide. Our results identify how antimicrobial resistance genes can be spread by plasmids through a number of mechanisms: direct plasmid transfer by conjugation; horizontal transmission into other plasmids; and transfer into the host chromosome. These results are of broad significance in the fields of bacterial genomics, plasmid biology and antimicrobial resistance. The results advance our knowledge of how plasmids can survive within bacterial hosts that have the ability to produce bloodstream invasion, and how they can spread antimicrobial resistance genes to other bacterial strains. We demonstrate linkage of different antimicrobial resistance genes on plasmids, which will allow co-selection of genes mediating very broad antibiotic resistance even when using a narrow-spectrum agent. Targeting plasmid-mediated antimicrobial resistance thus presents a significant challenge; our results provide a better understanding of how such plasmid-mediated resistance might be tackled in the future.

Introduction

Resistance to antimicrobial drugs is now widespread in many bacteria, associated with a poorer outcome from infection and increased costs to healthcare systems [1, 2]. In the USA, antibiotic resistant organisms in 2014 were estimated to cause over two million infections and 23 000 deaths [3], while estimates in Europe from 2015 reported 33 000 deaths from such infections, about 75 % of which were healthcare-associated [4]. A report in 2015 chaired by Jim O’Neil estimated that between 2014–2050 the world economy would lose up to 100 trillion US dollars of economic output if the spread of antimicrobial resistance is not checked [5].

Bloodstream invasion by bacteria represents one of the most severe consequences of infection, the commonest isolate being the Gram-negative pathogen Escherichia coli , responsible for about one-third of such infections worldwide [6], and showing a steady increase in incidence over the last 10 years [7–9]. Antibiotic resistance in these isolates is widespread and rising. Of particular concern is the rise in incidence of E. coli expressing extended spectrum β-lactamases (ESBL) which produce resistance to 3rd generation cephalosporins - in England in 2017 13 % of bloodstream isolates of E. coli were resistant to 3rd generation cephalosporins [10], while within Europe the rate was 14.9 % [11]. Similar rates are reported from the USA [12]. Thirty day mortality from bloodstream E. coli infections is reported to be about 10–20 % in a number of studies [13–15]. Such infections with ESBL-producing E. coli have a worse prognosis [16], particularly if initial therapy is with a third-generation cephalosporin [17]. Rates of resistance to other commonly broad-spectrum antibiotics are also common in E. coli, and frequently co-exist; in the European Union in 2017, 6.3 % of E. coli isolates had combined resistance to fluoroquinolones, third-generation cephalosporins and aminoglycosides.

The genetic basis of antibiotic resistance is generally well understood. For example, ESBLs are encoded by a number of genes [18], but those of the CTX-M class are some of the most widespread and increasing in incidence [19]. In particular, the CTX-M15 variant is common and geographically widespread [20], particularly in the epidemic ST131 lineage [21]. bla CTX-M and other antibiotic-resistance encoding genes are frequently found on plasmids [22]. These autonomously replicating genetic elements can spread through vertical transmission of parent to offspring, but also by horizontal transmission through bacterial conjugation [23]. Plasmids will place a potential selection burden on the cells in which they exist, since replication and translation of plasmid genes will have a negative fitness cost [24]. Thus, antibiotic usage will provide a selective pressure for plasmid maintenance. However, plasmids can survive even in the absence of antibiotic selection, through other mechanisms such as post-segregational killing systems that encode a stable toxin and labile anti-toxin [25], as well as co-evolutionary adaptations in host chromosome and plasmid that reduce fitness costs [26]. Moreover, antibiotic resistance genes can be mobilised from plasmid to chromosome, removing the need for continued antibiotic presence for maintenance [27]. Such genetic mobility also allows plasmids from different microbes to recombine, producing novel plasmids, as well as acquiring new antibiotic-resistance genes.

Horizontal gene transfer and the other factors described in the previous paragraph contribute to the complexity of antimicrobial resistance. Transfer of antibiotic-resistance genes between microbes may increase their spread in pathogenic bacteria. Transfer of these genes from bacteria in farm and other animals may also be significant [28]. Strict control of antibiotic usage has limited the prevalence of some antibiotic-resistant genes, but is not universally the case [29]. Use of narrow-spectrum agents might also limit the generation of resistance to broader spectrum agents, although genetic linkage of determinants of resistance might lead to inadvertent co-selection of resistance to both. Moreover, experimental studies have shown that acquisition of multiple antibiotic resistance genes can offset the fitness cost of either, a genetic interaction known as reciprocal sign epistasis [26, 30]. To what extent these mechanisms are operative in natural communities of pathogenic E. coli causing disease in humans is not clear.

In order better to understand the origin, maintenance and spread of antimicrobial resistance determinants within human pathogenic bacteria, we have undertaken a detailed genetic analysis of bloodstream isolates of E. coli from patients in Scotland [31]. In this study, we have combined short and long-read genome sequencing of 16 E. coli bloodstream isolates of the common ST131 and ST69 lineages to reconstruct the complete chromosomal and plasmid structure of these microbes. A total of 46 plasmids were reconstructed and antibiotic resistance genes in these elements and the corresponding bacterial chromosome analysed. The plasmids were highly heterogeneous with evidence of large amounts of rearrangement by horizontal transfer, both from other E.coli strains as well as other Enterobacteriacae. bla CTX-M15 genes had re-arranged in some strains into the chromosome alone (five strains), while others contained plasmid copies alone (two strains). Integrons containing multiple antibiotic genes were widespread in plasmids, notably many with a DfrA7 gene encoding resistance to trimethoprim, thus linking trimethoprim resistance to the other antibiotic resistance genes within the plasmids. Our findings show the impact of horizontal spread of antibiotic resistance genes, and mechanisms allowing spread and transmission.

Methods

Assembly of sequences

DNA was extracted for short-read Illumina sequencing of 162 genomes at the Wellcome Sanger Centre, UK as described in Goswami et al. [31]. For long-read sequencing 16 strains were selected based on higher numbers of ABR genes and plasmid replicons, and was conducted using PacBio SMRT sequencing at the Norwegian Sequencing Centre, University of Oslo, Norway. Two 8-sample multiplex libraries (8-plex) were created and run on separate SMRT cells (PacBio RS2). High quality finished genomes for these 16 genomes were constructed, using both long and short-reads, by hybrid assembly method of UniCycler v4.0.0 (31) under normal mode of assembly, keeping other settings as default. The assembled circular genomes and circular plasmids were then annotated with Prokka v1.11 [32].

Phylogenetic tree construction

Using the Prokka-annotated genomes, the pan-genomes were investigated for protein clustering using Roary [33] (>95 % amino acid identity). The 44 completed circular plasmid sequences were then extracted and a gene phylogenetic ML tree [34] was built to look into the gene similarity within the plasmids.

Antibiotic gene and Toxin/Antitoxin pair identification

SRST2 [35] was used on short-reads to determine ABR gene from ARG-Annot database [36], virulence determinants from VirulenceFinder [37] database and plasmid replicon genes from PlasmidFinder [38] database. For identification of these genes in the hybrid assembled contigs, BLASTn (>90 % coverage and >90 % identity) search was performed against them. An inhouse curated database was used for toxin-antitoxin gene identification. Comparison of sequences was done using Artemis genome visualization [39] and EasyFig [40].

Integron identification

IntegronFinder [41] identified the Class I integron cassettes and the CALIN cassettes within the assemblies with a maximum threshold for the attC sites as 200 bp and a minimum as 40 bp.

Global ST69 comparisons

An additional 328 ST69 isolates were collected from Enterobase v1.1.2; these are listed with their accession numbers in Table S1. The E. coli strain UMN026 (Accession NC_011751.1) was used as the reference genome to map all 328 short-read sequences (including 11 isolates from Scotland). The variants were then identified using VarScan [42] and recombination regions were filtered by Gubbins [43]. The midpoint rooted SNP based phylogenetic tree was built using RAxML [34]. De novo assembly of the short-read sequences was performed using SPAdes v3.8.1 [44] assembler. To identify plasmid homologous regions within these short-read sequences, p1ESCUM (Accession CU928148.1, 122 301 bp long) plasmid was divided into six contiguous segments based on its homogeneity (>97 % identity) with complete IncF plasmids (Fig. 4). These six segments were blasted (for >90 % identity threshold) against the de novo assembled contigs for percentage of coverage of those regions within 328 isolates. The coverage of three gene cassettes (Class I integron, strA-B module and mer module) were also calculated using BLASTn.

Fig. 4.

Fig. 4.

Comparison of Global ST69 Isolates. The UMN026 strain was used as reference genome to map the sequencing reads after masking out the mobile genetic regions. The variants were then identified using VarScan and recombinations were filtered by Gubbins. The midpoint rooted phylogenetic tree is built using RAxML. The x-axis of the tree represents the number of base substitutions along the length of the edges of the tree. The * in the tips of the tree indicates 11 of the 24 ST69 Scottish isolates from [31]; the others were much less related to the global isolates and formed an outlier group on the phylogenetic tree and were thus removed for ease of visualisation of the whole ST69 group . The panels to the right show the coverage of reads over p1ESCUM and the various resistance modules indicated to the right.

Conjugation

Bacterial conjugation was performed as described by Johnson et al. [45]. Briefly, two donor strains (EC0_10 and EC1_72) and a recipient strain, resistant to rifampicin (DH10B), were grown overnight LB broth without antibiotics. Strains were diluted 1 : 100 in fresh LB and grown for 4 h. Donor and recipient strains were mixed at a ratio of 1 : 10, respectively, and incubated for 18 h without shaking at 37 ˚C. The cultures were heavily vortexed before serial dilutions and plating onto LB agar containing; ampicillin (100 µg ml−1) or cefotaxime (1 µg ml−1) for donor selection, with and without rifampicin (100 µg ml−1), for recipient background selection. The strain conjugation combinations were performed in triplicate. Transconjugant and donor colony forming units were determined by serial dilutions and results are expressed as transconjugants per donor cell input. The lower limit of detection was 10−8 transconjugants per donor cell; conjugations were repeated three times.

Mahalanobis distance determination

Mahalanobis distances of the plasmids from their corresponding chromosomes were calculated using the method described by Suzuki et al. [46] and inhouse scripts in R v3.5.3. First, the dinucleotide relative frequencies of the chromosomes were calculated, with a moving window of 5 kb length, along the length of each chromosome as well as plasmids. These frequencies were then used to calculate the value of D2 using function ‘Mahalanobis’ under R package stats. This metric is a measure of the similarity between the sequences of plasmids and their hosts, and has been shown to be a reliable indicator of the similarity of plasmids to their long term hosts. The absolute value of the Mahalanobis distance is difficult to interpret as its upper limit is boundless; a more useful comparator is a derived p value which is the probability of the observed value of the Mahalanobis value falling within the empirical distribution of Mahalanobis values for 5 kb segments of the bacterial chromosome. A value approaching one shows high similarity between plasmid and chromosome, a low value the converse. The empirical p values were evaluated as frequency of number of plasmid fragments that are greater than the mean distance of a plasmid from its corresponding chromosome. Similar dinucleotide compositions between a plasmid and chromosome gives a p-value close to one whereas p-values close to zero indicate large distances and dissimilar dinucleotide compositions between a plasmid and chromosome.

Results

Selection of bloodstream isolates of E. coli for plasmid and chromosomal sequencing

We have recently analysed 162 bloodstream isolates from patients within Scotland in the years 2013–2015 [31]. The two commonest sequence types (ST) were ST131 and ST69 comprising 24 and 16% respectively of the total isolates. ST131 was predominantly isolated in healthcare-associated infection while ST69 was more associated with community-acquired cases [31]. We picked 16 of these isolates for further sequencing using single molecule real time sequencing, 12 ST131 and four ST69 isolates. These isolates were chosen based on being representative of the dominant ST populations, and contained a variety of antimicrobial resistance determinants. We selected isolates that short-read sequences indicated contained the gene for CTX-M15, the main extended spectrum β-lactamase in this collection, and a range of plasmid replicons as identified from short-read sequences. In ST131 and ST69, IncF replicons were present in >95 % of the strains from this collection [31]. This is only a small sample from the whole sequenced collection of bloodstream isolates, but we felt would provide insights into the origin, spread and persistence of antimicrobial resistance genes in representative examples of the E. coli bloodstream isolates. A maximum likelihood phylogenetic tree based on the core genomes of these isolates is shown in Fig. S1 together with their content of antimicrobial resistance genes identified from short-read sequencing. This shows the close genetic relationship as expected between the isolates from the same ST group.

We were able to complete plasmid assemblies for 46 plasmids from these isolates by combining the short (Illumina) and long-reads (PacBio) using the Unicycler pipeline [47]; the details of the isolates and plasmids are shown in Table 1. The identified source of the infection was classed as urine for eight of the 16 isolates. Seven of the isolates were resistant to cefotaxime and thus suspected to harbour an ESBL. For the isolate ECO_56, Unicycler was unable to bridge completely two IncF plasmids: ECO_56_C3 and ECO_56_C4. The contigs from these assemblies are very accurate but they have been omitted from some of the analyses where indicated.

Table 1.

Summary of the Sequenced Plasmids. Resistance (R) or sensitivity (S) to antibiotics is as shown, with abbreviations as follows: TMP. Trimethoprim; CTX, cefotaxime; Gen, gentamicin; AMC, co-amoxiclav; TZP, piperacillin/tazobactam. Minimum inhibitory concentrations (mg l–1) for AMC and TZP are shown in parentheses. Accession number at European Nucleotide Archive

Strain

Plasmid

Inc Group

Inc Subgroup

Length

Source of Infection

ST

TMP

CTX

Gen

AMC

TZP

bla

OXA-1

bla

CTX-M-15

Accession Number

EC0_10

Urine

ST131

R

R

R

R

(32)

S

(8)

+

+

GCA_902668725

EC0_10_C2

Others

ColRNAI

112708

GCA_902668725

EC0_10_C3

IncF

IncFII/FIBA

106970

GCA_902668725

EC0_10_C4

Col

ColD

5631

GCA_902668725

EC0_10_C5

Others

na

4082

GCA_902668725

EC0_33

Bile

ST131

R

R

S

S

(8)

S (<4)

+

+

GCA_902668635

EC0_33_C10

Col

ColMG828

1546

GCA_902668635

EC0_33_C3

IncF

IncFII/FIA

117124

GCA_902668635

EC0_33_C4

Others

p0111_1

98 727

GCA_902668635

EC0_33_C5

Others

X4/X4TaxC

33 138

GCA_902668635

EC0_33_C6

Col

ColRNAI

3244

GCA_902668635

EC0_4

Urine

ST69

R

S

R

S

(8)

S

(<4)

GCA_902668655

EC0_4_C3

IncF

IncFII/FIBA/P

98 010

GCA_902668655

EC0_4_C4

Col

ColD

5631

GCA_902668655

EC0_4_C5

Col

Col156

5166

GCA_902668655

EC0_4_C6

Col

Col8282

4072

GCA_902668655

EC0_42

Respiratory

ST131

R

S

R

R

(16)

S

(<4)

GCA_902668695

EC0_42_C2

IncF

IncFII/FIBA

144047

GCA_902668695

EC0_56

Unknown

ST131

R

R

R

R

(16)

S

(8)

+

+

GCA_902668675

EC0_56_C3*

IncF

IncFII/FIBA/FIA

155220

GCA_902668675

EC0_56_C4*

IncF

IncFII

59 851

GCA_902668675

EC0_56_C5

Others

11 371

GCA_902668675

EC0_73

Unknown

ST69

R

R

R

R

(32)

S

(8)

GCA_902668625

EC0_73_C3

IncF

IncFII/FIBA/Q

142696

GCA_902668625

EC0_73_C4

Col

ColD

4409

GCA_902668625

EC0_73_C5

Col

Col8282

4072

GCA_902668625

EC0_73_C8

Col

ColMG828

1549

GCA_902668625

EC0_76

Unknown

ST131

R

S

S

S

(2)

S

(<4)

+

+

GCA_902668665

EC0_76_C3

IncF

IncFII/FIBA/FIA

115340

GCA_902668665

EC0_76_C6

Col

ColBS512

2089

GCA_902668665

EC1_20

Unknown

ST131

S

S

S

S

(4)

S

(<4)

GCA_902668595

EC1_20_C2

IncF

IncFII/FIBA/FIA

50 894

GCA_902668595

EC1_20_C3

Col

ColRNAI

5631

GCA_902668595

EC1_20_C4

Col

Col8282

4082

GCA_902668595

EC1_25

Urine

ST131

S

S

S

R

(32)

S

(8)

+

GCA_902668705

EC1_25_C2

IncF

IncFII/FIA

132945

GCA_902668705

EC1_25_C4

Col

ColK

6888

GCA_902668705

EC1_25_C5

Col

ColMG828

1546

GCA_902668705

EC1_36

Urine

ST69

R

S

S

S

(8)

S

(<4)

GCA_902668585

EC1_36_C2

IncF

IncFII/FIBA/Q

149279

GCA_902668585

EC1_36_C3

Col

Col156

5165

GCA_902668585

EC1_36_C4

Col

Col8282

4072

GCA_902668585

EC1_36_C5

Others

2377

GCA_902668585

EC1_5

Urine

ST69

R

S

S

S

(4)

S

(<4)

GCA_902668645

EC1_5_C2

IncF

IncFII/FIBA/Q

147684

GCA_902668645

EC1_50

Urine

ST131

R

R

R

R

(16)

I

(16)

+

+

GCA_902668605

EC1_50_C2

IncF

IncFII/FIBA/FIA

170727

GCA_902668605

EC1_6

Urine

ST131

R

R

R

R

(32)

R

(128)

+

+

GCA_902668615

EC1_6_C5

IncF

IncFII/FIBA/FIA

75 763

GCA_902668615

EC1_6_C6

Others

X1TaxC

33 703

GCA_902668615

EC1_6_C9

Col

ColBS512

2089

GCA_902668615

EC1_72

Urine

ST131

R

R

R

R

(16)

S

(8)

+

+

GCA_902668685

EC1_72_C13

Others

1549

GCA_902668685

EC1_72_C15

Col

ColMG828

1459

GCA_902668685

EC1_72_C4

IncF

IncFII/FIA

91 615

GCA_902668685

EC1_72_C5

IncF

IncFII

70 705

GCA_902668685

EC1_72_C7

Col

Col156

5164

GCA_902668685

EC1_72_C9

Col

Col8282

4087

GCA_902668685

EC1_77

Unknown

ST131

R

S

S

S

(8)

S

(8)

GCA_902668715

EC1_77_C2

IncF

IncFII/FIBA

108851

GCA_902668715

EC1_87

Bile

ST131

R

S

R

S

(8)

S

(<4)

GCA_902668575

EC1_87_C5

IncF

IncFII/FIBA/FIA

170376

GCA_902668575

Phylogenetic tree of plasmid accessory genome, replicon types and antibiotic resistance genes

Analysis of the gene content of all the 46 fully reconstructed plasmids revealed a total of 916 genes, 133 of these being shell genes (found in >15 % but <95 % of plasmids); the remaining 783 genes were cloud genes (found in <15 % of plasmids). There were no core genes. Inc F plasmids had the highest percentage of cloud genes (50.0 % of total genes); col and others were much lower (16.7 and 1.24% respectively; Table S2). A phylogenetic tree based on the accessory genome of the plasmids is shown in Fig. 1, together with the replicon types of the plasmids, antibiotic resistance genes, and toxin/antitoxin pairs. Comparison of the different plasmid groups shows that the IncF plasmids were more divergent than the col-type plasmids. Broadly the plasmids fell into three replicon groups: IncF, col-type and others. The larger IncF group plasmids were more diverse than the col plasmids. Plasmids within the IncF group showed multiple F replicons, a feature previously noted using hybridisation assays [48]; three IncF group plasmids also contained IncQ replicon sequences. Whether these different replicons are all functionally active remains to be shown. However, it is notable that of the 16 IncF plasmids, four have four IncF origins, seven have three, two have two, and three just one. This bias towards multiple IncF replicons suggests a positive selection pressure favouring such multiple replicons. This would tend to restrict entry of other IncF plasmids because of plasmid incompatibility and thus a means of these IncF plasmids from preventing entry of other IncF plasmids into the same bacterial cell. Indeed, all but one (EC1_72) of our sequenced strains contained just one IncF plasmid; EC1_72 contains two IncF plasmids, with different replicons. In contrast, plasmids with col replicons typically have only one replicon; of 20 exclusively col replicon containing plasmids, 15 have just one replicon, a significantly different distribution from the IncF plasmids (P<0.001, Chi-squared test).

Fig. 1.

Fig. 1.

Phylogenetic tree of plasmid isolates. Maximum likelihood phylogenetic tree based on accessory gene content was constructed using RAxML as described in the Methods; bootstrap support values for the tree were greater than 80 %. The tables to the right show antibiotic resistance genes, toxin-antitoxin pairs within the plasmids, and the Inc grouping of each plasmid, based on the database used with PlasmidFinder [38]. IncF groups are coloured red, col type blue and others as green. The resistance determinants were found using ARIBA and the CARD database.

The presence of antibiotic resistance genes within these plasmids is also shown in Fig. 1. Resistance genes were present almost exclusively within the IncF group; one plasmid of unknown incompatibility group did contain some resistance genes (ECO_56_C5). No col-type plasmids contained antibiotic resistance genes. Also shown in Fig. 1 is the presence of toxin/antitoxin pairs important as part of plasmid maintenance through postsegregational killing mechanisms [49]. Again, these are restricted almost exclusively to the IncF plasmid group.

IncF Plasmids

As the antibiotic resistance genes resided almost exclusively within the IncF plasmid group, we analysed these in more detail. A detailed phylogenetic tree of these plasmids and the regions of similarity is shown in Fig. 2a. Five of these plasmids showed significant overall homology: ECO_73_C3, EC1_36_C2, EC1_5_C2 (all from ST69) and ECO_42_C2 and EC1_77_C2 (both ST131). The remainder showed considerable differences, although with obvious elements of homology, and with marked rearrangements.

Fig. 2.

Fig. 2.

Homology between the IncF Plasmids. The phylogenetic tree of the plasmids is shown to the left. An additional non-IncF plasmid that is closely related is included (ECO_56_C5); only the integron cassettes are shown for this plasmid. The panels to the right show: (a) the outline genetic map of each plasmid with areas of homology between each successive plasmid shaded; the degree of homology is graded as shown by the key; (b) and (c) the identified integron (b) and CALIN (c) cassette elements. The integron recombination sites attI and attC are as shown.

Distribution of Integrons within IncF Plasmids

Given the importance of integrons in mediating and transferring antibiotic resistance, we sought the presence of integrons in all the IncF plasmids sequenced [50–52]. Examination of the IncF plasmid sequences using the program IntegronFinder [41] revealed the presence of the Class I integron discussed above containing the genes dfrA7 and aadA4 downstream of the intI gene, together with the conserved sulI and qacEΔ elements of the class I integron [53] in 15 of the IncF plasmids (Fig. 2b).

We also found clusters of attC sites lacking integron-integrases, so-called CALIN elements [41], both within some of the IncF plasmids and in two strains, within the chromosome (Fig. 2c). These all contained the antibiotic resistance genes bla OXA-1 and Aac6-Ib, encoding a beta-lactamase and an aminoglycoside modification enzyme respectively. These genes were tightly linked to the extended spectrum beta lactamase, bla CTX-M15, and are considered in more detail below.

Relationship of Plasmids to p1ESCUM

The five plasmids with greatest overall homology (ECO_73_C3, EC1_36_C2, EC1_5_C2 (all from ST69) and ECO_42_C2 and EC1_77_C2 (both ST131)) were analysed in greater detail. Homology search of these related plasmids using blast identified high homology with an E.coli plasmid p1ESCUM in strain UMN026 (ST69), isolated in 1999 from a woman with uncomplicated acute cystitis in 1999 in the USA. The percentage identity and coverage are shown in Table S3. Detailed comparison of these plasmids is shown in Fig. 3. Sequences encoding the replicon, type IV conjugal transfer functions and other plasmid backbone features are highly conserved between the different plasmids. p1ESCUM contains very few antibiotic resistance genes. However, the homologous IncF plasmids contain a variety of insertions into the p1ESCUM backbone that contain a variety of antibiotic resistance genes. All the plasmids contain insertions of a Class I integron containing the genes dfrA7 and aadA4, mediating resistance to trimethoprim and streptomycin/spectinomycin respectively [54, 55]. This integron has been found in the IncF plasmid pEK499 from an ST131 E. coli [56] and a closely related dfrA17-aadA5 cassette has been described in a collection of uropathogenic E. coli isolated form urine samples of college students in the USA [57]. The ARG-ANNOT data base groups the highly similar dfrA17 and dfrA7 together, with a designation dfrA7. This resistance determinant was found in 28 % of the total 162 Scottish genomes analysed. It was more prevalent in the ST131 and ST69 strains, at 69 and 50 % respectively, in both cases a significant difference from the total population (two sample z test, P<0.001 and<0.05 respectively) . In addition, all the plasmids contain the linked sulII/strA/strB/ gene cassette, mediating resistance to sulphonamides and streptomycin. This cassette is widespread in mobile genetic elements of a variety of bacteria [58]. Finally, it is notable that all the plasmids contain inserted sequences containing elements of the mer operon, a genetic system that encodes proteins responsible for detoxification of Hg++ and organomercury compounds to the relatively harmless and volatile Hg0 [59, 60]. The relevance of these genes is considered further in the discussion. These different inserted elements are present on a variety of known mobile elements, including transposon TnAs3, initially described in a plasmid of Aeromonas salmonicida [61] and also described in plasmids mediating broad antibiotic resistance in strains of Klebsiella pneumoniae [62].

Fig. 3.

Fig. 3.

Comparison of 5 IncF Plasmids with p1ESCUM. The indicated plasmids are shown relative to the reference plasmid p1ESCUM. The insertions into the p1ESCUM backbone are highlighted, with genes and mobile elements as shown.

Distribution of p1ESCUM elements and IncF Plasmid Resistance Genes in Global ST69 E. coli Isolates

p1ESCUM was isolated from a ST69 E.coli strain as were three of the plasmids described above which showed high homology to this plasmid. We wished to determine how widespread this plasmid and derivatives might be in a wider sample of ST69 isolates from different geographical areas, to determine if such homology was also found more widely than strains analysed in our local collection. Long-reads are not available for the vast majority of sequenced bacterial strains, so we were not able to reconstitute complete plasmid sequences. However, we interrogated sequences from 328 ST69 isolates from different geographical areas for the presence of different segments of p1ESCUM and the three resistance gene cassettes identified in plasmids ECO_73_C3, EC1_36_C2, EC1_5_C2 and ECO_42_C2 described above (Table S1,Fig. 4). Conservation of the indicated elements does not imply they are in the original p1ESCUM backbone (or indeed necessarily all together in the same plasmid), as gene rearrangements will lead to reassortment of these sequences into other genetic locations. However, the observed distribution shows widespread presence of homologues of p1ESCUM elements in this collection of ST69 isolates, but not in all. The three resistance cassettes identified above had a more restricted distribution, with clear phylogenetic grouping (Fig. 4). Flux of these elements into or out of these strains has thus occurred on multiple occasions.

Distribution of CTX-M15 and OXA-1 within IncF Plasmids and Chromosomes

Seven of the 16 strains fully sequenced contained the bla CTX-M-15 encoding an extended spectrum beta-lactamase (Table 2). In two cases this was present in a plasmid, while it was in the chromosome in the remaining five. A number of other antibiotic resistance genes were tightly linked to the bla CTX-M-15 gene, including the bla OXA-1 and aac(6’)Ib gene contained on a CALIN as described above. The distribution of the bla CTX-M-15 and bla OXA-1 genes between plasmids and chromosome is shown in Table 2. Fig. 5a shows a comparison of the plasmid location of this element in EC0_10_C3 and in the chromosome of EC1_50_C1. The element is flanked by IS26 sequences and also contains Tn3 transposase components, suggesting these have been important in its dissemination, a role previously noted for IS26 elements within ST131 E. coli [63, 64]. In two cases, the bla CTX-M-15 gene is located in the chromosome, while the bla OXA-1 gene is contained on a plasmid; this is shown for the ECO_76 strain in Fig. 5b. Insertion sequence mediated re-arrangements would appear to be instrumental in this rearrangement. In one case, only the bla OXA-1 gene is present, in plasmid EC1_25_C2; the bla CTX-M-15 gene is not present in either chromosome or plasmid (Fig. 5c). Again, insertion sequences seem to be responsible for these rearrangements. These data provide a genetic basis for the recently observed co-carriage of bla CTX-M-15 and bla OXA-1, mediating resistance to piperacillin/tazobactam and co-amoxiclav, as well as aac(6’)Ib, mediating resistance to amikacin and tobramycin [65]. Presence of the bla OXA-1 gene was associated with an increase in the MIC to co-amoxiclav from 8 to 16 mg l−1 and for piperacillin/tazobactam from <4 to 8 mg l−1; neither of these shifts were significant between the groups, nor was association between resistance and presence of bla OAX-1. However, the numbers here are much smaller than those analysed in Livermore et al. [65]. One isolate (ECO_73) without bla CTX-M-15 was resistant to cefotaxime, presumably through upregulation of chromosomal bla AMP-C. One isolate (ECO_76) with chromosomal bla CTX-M-15 was sensitive to cefotaxime; there were no sequence alterations in the coding sequence, so this most probably reflects low expression.

Table 2.

Location of bla CTX-M-15 and bla OXA-1 genes within the indicated strains

Strain

bla CTX-M-15

bla OXA-1

EC0_10

Plasmid: EC0_10_C3

Plasmid: EC0_10_C3

EC1_72

Plasmid: EC1_72_C4

Plasmid: EC1_72_C4

EC1_50

Chromosome

Chromosome

EC0_33

Chromosome

Chromosome

EC0_56

Chromosome

Chromosome

EC0_76

Chromosome

Plasmid: EC1_76_C3

EC1_6

Chromosome

Plasmid: EC1_6_C5

EC1_25

Absent

Plasmid: EC1_25_C2

Fig. 5.

Fig. 5.

Plasmid and chromosomal positions of bla CTX-M-15 and bla OXA-1. (a) shows locations in indicated plasmid and chromosome. Genes and mobile elements are highlighted. The blue block designates the element containing the bla OXA-1 and aac(6’)ib-cr gene. (b) shows location of bla OXA-1 in chromosome and bla OXA-1 in plasmid. (c) shows location of bla OXA-1 alone in plasmid.

The relocation of plasmid-borne antibiotic resistance markers such as bla CTX-M-15 to the chromosome exemplifies aspects of ‘chromosomal imperialism’. Strong evolutionary pressure against plasmid carriage under conditions where plasmid borne genes are not providing benefit to the host will favour chromosomal relocation of potentially advantageous determinants such as genes encoding antibiotic resistance [24, 66]. Thus, survival of plasmids depends strongly on their ability to spread through conjugation [66]. Ten of the 16 IncF plasmids have a conserved specialised type IV secretion apparatus allowing them to be self-transmissible (Fig. S2), supporting the importance of conjugation in plasmid retention in bacterial populations. However, synthesis of the specialised type IV secretion system places a fitness burden on the host, as well as allowing phage predation. Experimental studies have shown that large plasmids eliminate segments encoding the type IV secretion machinery under conditions of continued growth [67], although removing self-transmissibility and thus potentially consigning such plasmids to an evolutionary dead end. Six of the IncF plasmids sequenced here have lost the gene sequences responsible for synthesis of the conjugative apparatus (Fig. S2), suggesting such loss of this portion of a plasmid is not uncommon in naturally occurring plasmid populations. Five of these six plasmids are the only IncF plasmid within their host strain, rendering them unable to spread by conjugation. One plasmid lacking the genes encoding the conjugative apparatus, EC1_72_C4, co-exists in its host with another IncF plasmid, EC1_72_C5 which does contain these genes, potentially allowing donation of transmissibility to the EC1_72_C4 plasmid. To test this, we carried out conjugation assays from the parent strains EC1_72 and ECO_10 (lacking a conjugation apparatus) to a recipient E. coli strain, DH10B (Fig. 6). As predicted, conjugal transfer of cefotaxime resistance mediated by the bla CTX-M-15 gene was successful at high frequency from the EC1_72 strain but below the limit of detectability for the ECO_10 strain.

Fig. 6.

Fig. 6.

Conjugation efficiency of plasmids. Graph shows the number of transconjugants per donor of transfer from the indicated strains. Columns are means of three determinations; standard error of the means were <0.01 % and are too small to show on the plot. The antibiotic used to select transconjugants is shown next to the strain used: AMP is ampicillin, CTX is cefotaxime. The lower limit of detection was 10−8 transconjugants per donor cell.

Evolutionary History of Plasmids within their Host

In order better to understand the origins of the different plasmids studied here, we wished to estimate how long they had been established in their respective hosts. Over time, ‘foreign’ DNA in a bacterium adopts a very similar composition to its host, a process known as genome amelioration [68]. We calculated the degree of similarity of the dinucleotide frequencies between each plasmid and its bacterial host using the Mahalanobis distance, as described in the Methods [46]. Empirical probability values for the different plasmids sequenced in the current study is shown in Fig. S3; as outlined in the Methods, identity between plasmid and chromosome composition would have a p value approaching one. As a reference, we also included two E. coli O157 strains (EDL933 and O157:H7 Sakai) that carry the pO157 plasmid, previously included in a study of the relationship between Mahalanobis value and plasmid/chromosome similarity [46]. As has been noted previously [46], there was a significant positive correlation between plasmid length and p value, such that the set of small col-origin plasmids were least like their host chromosome, and the bigger IncF plasmids most like their host chromosome. This suggests that the IncF plasmids are likely long-term residents of their hosts, while the smaller col plasmids may be shorter-term residents, potentially colonising a variety of different bacterial hosts. This would need to be verified using a larger set of complete plasmid sequences and their corresponding chromosomes.

Discussion

The results presented here provide a comprehensive analysis of the plasmids contained within a group of clinical bloodstream isolates of E. coli and associated antibiotic resistance genes. Genes conferring antibiotic resistance were almost exclusively located on IncF group plasmids found in all of the isolates, while there were also large numbers of cryptic small plasmids of the col incompatibility group. The IncF plasmids described here thus play a key role in mediating antibiotic resistance in the clinical bloodstream isolates of E. coli used in this study. Plasmids require a bacterial host for their continued existence but their existence within bacterial cells potentially places a fitness burden on their host, as significant metabolic activity must be expended for their replication. They have thus evolved mechanisms to resist elimination, such as: toxin/antitoxin pairs to avoid post-segregational loss; possession of genes that confer resistance to environmental stresses such as antibiotics or heavy metals; and the ability to transfer themselves to other hosts. However, blocks to segregational loss are not 100 % effective; resistance genes will only be selected in the face of constant environmental pressure; and conjugation rates do not appear high enough to ensure plasmid survival. Taken together, these blocks have not been thought to be sufficient to explain plasmid persistence, the so-called ‘plasmid paradox’ [69].

Antibiotic resistance will ensure bacterial and hence plasmid survival if the relevant resistance gene is carried on the plasmid. However, movement of the gene to the chromosome will retain the selective advantage of resistance but remove the fitness cost of replicating a large plasmid. The gene for the extended spectrum β-lactamase CTX-M-15 was found in seven of the 16 isolates studied here, but only in two of these was it contained within a plasmid; the rest were found in the chromosome. This is in keeping with the postulated evolutionary pressure for plasmid-borne selectable markers to move to the chromosome. Other genes mediating antibiotic resistance show a similar pattern of spread to the chromosome – the bla OXA-1-aac6-1b cassette carried on CALIN has moved to a chromosomal location in two of the strains. Other determinants, however, are only found on plasmids such as the integron cassette with the dfrA7 and aad4 genes. While the selective advantage of antibiotic resistance genes is clear, at least for areas of high usage such as hospitals, it is not clear why there has been retention of the mer operon within plasmids that mediates resistance to mercury salts. Mercuric compounds were used extensively in agriculture up to the 1970s, which may have provided a selective advantage for these genes originally for environmental survival of bacteria carrying mer-containing plasmids [70, 71]. What selective advantage they now mediate is less clear. One possible explanation for their retention is their co-selection with closely linked genetic elements such as antibiotic resistance genes that confer benefit – such as bla CTX-M-15 and bla OXA-1. This may also explain the persistence of the sulII/strA/strB/ cassette mediating resistance to sulphonamides and streptomycin. Although used extensively in the past, these antibiotic are not used to any great degree currently; again, co-selection with linked genes such as dfrA7 mediating trimethoprim resistance may play an important role; trimethoprim is used extensively and remains the first-line drug for treatment of uncomplicated urinary tract infections within Scotland. Such co-selection also calls into question the perceived advantages of narrow spectrum antibiotic prescribing, in order to reduce selection for broad spectrum antibiotics. For many of the plasmids described here, use of trimethoprim would confer a selection advantage to dfrA7 containing plasmids that also mediate resistance to extended spectrum β-lactamases, thus inadvertently selecting for these resistances in addition. Importantly, we have also shown close genetic linkage between bla CTX-M-15 and bla OXA-1, explaining the recently observed association between these two determinants, resulting in extended spectrum β-lactamase activity being associated with resistance to co-amoxiclav and reduced sensitivity to piperacillin/tazobactam [65].

The universal presence of IncF plasmids within the 16 isolates described here and in the majority of the 162 isolates previously analysed [31] shows these plasmids are successfully maintained within this population of E. coli . The ability to spread by horizontal gene transfer is another key factor in their survival. Ten of the 16 IncF plasmids have a specialized type IV secretion apparatus that can mediate conjugative spread; one bla CTX-M-15 containing plasmid without this apparatus was successfully transferred by donation from a co-resident self-transmissible plasmid. However, five of the IncF plasmids are not self-transmissible and do not co-exist with a donor plasmid. Long term survival of these plasmids would thus be predicted to be doomed. In addition, these plasmids typically contain more than one IncF replicon, thus preventing uptake of any additional plasmid containing these replicons. Co-evolution of plasmid and host has been shown to ameliorate the negative fitness of plasmid carriage [72], and might contribute to these plasmids survival. Movement of plasmids into new fitter hosts that ‘sweep’ through a bacterial population has also been proposed as a mechanism for continue bacterial survival [66], although this would not be possible for plasmid/host combinations that lack the ability for transfer by conjugation.

In order to better understand how such plasmids bearing antibiotic resistance might spread, we attempted to determine how long they had been present in their hosts and the degree to which they had spread within bacterial populations. Strong homology of three of the IncF plasmids within ST69 strains to the plasmid p1ESCUM allowed us to interrogate a range of available ST69 sequences for the presence of similar elements. Although long-reads are not available for most of these sequences, and hence exact plasmid sequences are not known, we were able to demonstrate widespread possession of p1ESCUM elements within the ST69 lineage, with the antibiotic and mercury resistance elements we identified having a more limited distribution related to phylogenetic origin. This suggests strongly that this plasmid family has been present over significant periods of time and elements have been gained and lost in different sectors of the ST69 lineage. Analysis of the nucleotide similarity between host chromosome and IncF plasmids using the Mahalanobis distance also supports the view that the IncF plasmids are long term hosts of E. coli and have not been gained more recently from another bacterial species.

In conclusion, the ability to combine long and short whole genome sequencing reads allows fast and accurate reconstruction of the total plasmid population of bacterial isolates from bloodstream isolates. This has allowed a detailed analysis of the important antibiotic resistance elements present within plasmid and chromosome and how they are spread and retained. The close genetic linkage of many resistance elements has important clinical implications, as co-selection of resistances will occur even when using a narrow spectrum antibiotic, thus rendering antibiotic governance strategies impotent against the spread of resistance to agents such as third generation cephalosporins.

Data Bibliography

1. Short-read Illumina sequences were deposited under accession PRJEB12513.

2. The raw FAST5 PacBio sequences and Unicycler assemblies were submitted under the project accession PRJEB33761.

3. The global ST69 isolates with their accession details are in Table S1.

Supplementary Data

Supplementary material 1
Supplementary material 2

Funding information

The work was funded by the Scottish Executive via the Chief Scientists Office through the provision of a grant to establish the Scottish Healthcare Associated Infection Prevention Institute (SHAIPI). The funders had no role in the study design; collection, analysis or interpretation of data; writing of the manuscript.

Author contributions

Conception of study: T.E., M.H., A.L.; Strain identification and characterisation: A.L., M.C.; Data generation and analysis, C.G., S.F., T.E., M.H. Writing of manuscript: all authors

Conflicts of interest

The authors declare that there are no conflicts of interest.

Ethical statement

Advice was sought from the Local Research Ethics Committee of Greater Glasgow and Clyde NHS Board. Specific ethical permission was deemed not to be required as the study was viewed as service improvement. Approval for access to clinical patient data was given by the Caldicott Guardian of the relevant health boards, who is the designated regulator of confidential patient information within NHS Scotland.

Footnotes

Abbreviations: ABR, antibioitc resistance; CALIN, clusters of attC sites lacking intergon-integrases; E. coli, Escherichia coli; ENA, European Nucelotide Archive; ESBL, extended spectrum beta-lactamase; ST, sequence type.

All supporting data, code and protocols have been provided within the article or through supplementary data files. Three supplementary tables and three supplementary figures are available with the online version of this article.

All genome data for this study have been deposited in European Nucleotide Archive (ENA). Short read Illumina sequences were deposited under accession PRJEB12513. The raw FAST5 PacBio sequences and Unicycler assemblies were submitted under the project accession PRJEB33761.

References

  • 1.Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13:42–51. doi: 10.1038/nrmicro3380. [DOI] [PubMed] [Google Scholar]
  • 2.Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, et al. The epidemic of antibiotic-resistant infections: a call to action for the medical community from the infectious diseases Society of America. Clin Infect Dis. 2008;46:155–164. doi: 10.1086/524891. [DOI] [PubMed] [Google Scholar]
  • 3.U.S. Centers for Disease Control and Prevention Antibiotic resistance threats in the United States 2013. 2013.
  • 4.Cassini A, Högberg LD, Plachouras D, Quattrocchi A, Hoxha A, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19:56–66. doi: 10.1016/S1473-3099(18)30605-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.O’Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. 2014.
  • 6.Laupland KB. Incidence of bloodstream infection: a review of population-based studies. Clin Microbiol Infect. 2013;19:492–500. doi: 10.1111/1469-0691.12144. [DOI] [PubMed] [Google Scholar]
  • 7.Abernethy J, Guy R, Sheridan EA, Hopkins S, Kiernan M, et al. Epidemiology of Escherichia coli bacteraemia in England: results of an enhanced sentinel surveillance programme. J Hosp Infect. 2017;95:365–375. doi: 10.1016/j.jhin.2016.12.008. [DOI] [PubMed] [Google Scholar]
  • 8.Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003;5:449–456. doi: 10.1016/S1286-4579(03)00049-2. [DOI] [PubMed] [Google Scholar]
  • 9.Health Protection Scotland Healthcare associated infections. 2017. 2017.
  • 10.Public Health England English surveillance programme for antimicrobial utilisation and resistance (ESPAUR) report. 2018.
  • 11.European Centre for Disease Prevention and Control Surveillance of antimicrobial resistance in Europe – annual report of the European antimicrobial resistance surveillance network (EARS-Net) 2017. 2018.
  • 12.McDanel J, Schweizer M, Crabb V, Nelson R, Samore M, et al. Incidence of extended-spectrum β-Lactamase (ESBL)-Producing Escherichia coli and Klebsiella infections in the United States: a systematic literature review. Infect Control Hosp Epidemiol. 2017;38:1209–1215. doi: 10.1017/ice.2017.156. [DOI] [PubMed] [Google Scholar]
  • 13.Public Health England Thirty-day all-cause fatality subsequent to MRSA, MSSA and Gram-negative bacteraemia and C. difficile infection: 2017 to 20182019
  • 14.Laupland KB, Gregson DB, Church DL, Ross T, Pitout JDD. Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect. 2008;14:1041–1047. doi: 10.1111/j.1469-0691.2008.02089.x. [DOI] [PubMed] [Google Scholar]
  • 15.Vihta K-D, Stoesser N, Llewelyn MJ, Quan TP, Davies T, et al. Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records. Lancet Infect Dis. 2018;18:1138–1149. doi: 10.1016/S1473-3099(18)30353-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Anunnatsiri S, Towiwat P, Chaimanee P. Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand. Southeast Asian J Trop Med Public Health. 2012;43:1169–1177. [PubMed] [Google Scholar]
  • 17.Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, de Cueto M, et al. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis. 2006;43:1407–1414. doi: 10.1086/508877. [DOI] [PubMed] [Google Scholar]
  • 18.Ur Rahman S, Ali T, Ali I, Khan NA, Han B, et al. The growing genetic and functional diversity of extended spectrum beta-lactamases. Biomed Res Int. 2018;2018:9519718. doi: 10.1155/2018/9519718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Cantón R, González-Alba JM, Galán JC. Ctx-M enzymes: origin and diffusion. Front Microbiol. 2012;3:110. doi: 10.3389/fmicb.2012.00110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bevan ER, Jones AM, Hawkey PM. Global epidemiology of CTX-M β-lactamases: temporal and geographical shifts in genotype. J Antimicrob Chemother. 2017;72:2145–2155. doi: 10.1093/jac/dkx146. [DOI] [PubMed] [Google Scholar]
  • 21.Nicolas-Chanoine M-H, Bertrand X, Madec J-Y. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27:543–574. doi: 10.1128/CMR.00125-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Branger C, Ledda A, Billard-Pomares T, Doublet B, Fouteau S, et al. Extended-spectrum β-lactamase-encoding genes are spreading on a wide range of Escherichia coli plasmids existing prior to the use of third-generation cephalosporins. Microb Genom. 2018;4 doi: 10.1099/mgen.0.000203. 06 08 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Smillie C, Garcillán-Barcia MP, Francia MV, Rocha EPC, de la Cruz F. Mobility of plasmids. Microbiol Mol Biol Rev. 2010;74:434–452. doi: 10.1128/MMBR.00020-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.San Millan A, MacLean RC. Fitness costs of plasmids: a limit to plasmid transmission. Microbiol Spectr. 2017;5 doi: 10.1128/microbiolspec.MTBP-0016-2017. [DOI] [PubMed] [Google Scholar]
  • 25.Page R, Peti W. Toxin-antitoxin systems in bacterial growth arrest and persistence. Nat Chem Biol. 2016;12:208–214. doi: 10.1038/nchembio.2044. [DOI] [PubMed] [Google Scholar]
  • 26.Durão P, Balbontín R, Gordo I. Evolutionary mechanisms shaping the maintenance of antibiotic resistance. Trends Microbiol. 2018;26:677–691. doi: 10.1016/j.tim.2018.01.005. [DOI] [PubMed] [Google Scholar]
  • 27.Hülter N, Ilhan J, Wein T, Kadibalban AS, Hammerschmidt K, et al. An evolutionary perspective on plasmid lifestyle modes. Curr Opin Microbiol. 2017;38:74–80. doi: 10.1016/j.mib.2017.05.001. [DOI] [PubMed] [Google Scholar]
  • 28.Manges AR. Escherichia coli and urinary tract infections: the role of poultry-meat. Clin Microbiol Infect. 2016;22:122–129. doi: 10.1016/j.cmi.2015.11.010. [DOI] [PubMed] [Google Scholar]
  • 29.Enne VI, Livermore DM, Stephens P, Hall LM. Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet. 2001;357:1325–1328. doi: 10.1016/S0140-6736(00)04519-0. [DOI] [PubMed] [Google Scholar]
  • 30.Silva RF, Mendonça SCM, Carvalho LM, Reis AM, Gordo I, et al. Pervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutations. PLoS Genet. 2011;7:e1002181. doi: 10.1371/journal.pgen.1002181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Goswami C, Fox S, Holden M, Connor M, Leanord A, et al. Genetic analysis of invasive Escherichia coli in Scotland reveals determinants of healthcare-associated versus community-acquired infections. Microb Genom. 2018;4 doi: 10.1099/mgen.0.000190. 22 06 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Seemann T. Prokka: rapid prokaryotic genome annotation. Bioinformatics. 2014;30:2068–2069. doi: 10.1093/bioinformatics/btu153. [DOI] [PubMed] [Google Scholar]
  • 33.Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, et al. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics. 2015;31:3691–3693. doi: 10.1093/bioinformatics/btv421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics. 2006;22:2688–2690. doi: 10.1093/bioinformatics/btl446. [DOI] [PubMed] [Google Scholar]
  • 35.Inouye M, Dashnow H, Raven L-A, Schultz MB, Pope BJ, et al. SRST2: rapid genomic surveillance for public health and hospital microbiology Labs. Genome Med. 2014;6:90. doi: 10.1186/s13073-014-0090-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Gupta SK, Padmanabhan BR, Diene SM, Lopez-Rojas R, Kempf M, et al. ARG-ANNOT, a new bioinformatic tool to discover antibiotic resistance genes in bacterial genomes. Antimicrob Agents Chemother. 2014;58:212–220. doi: 10.1128/AAC.01310-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Joensen KG, Scheutz F, Lund O, Hasman H, Kaas RS, et al. Real-time whole-genome sequencing for routine typing, surveillance, and outbreak detection of verotoxigenic Escherichia coli . J Clin Microbiol. 2014;52:1501–1510. doi: 10.1128/JCM.03617-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58:3895–3903. doi: 10.1128/AAC.02412-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Carver T, Harris SR, Berriman M, Parkhill J, McQuillan JA. Artemis: an integrated platform for visualization and analysis of high-throughput sequence-based experimental data. Bioinformatics. 2012;28:464–469. doi: 10.1093/bioinformatics/btr703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sullivan MJ, Petty NK, Beatson SA. Easyfig: a genome comparison visualizer. Bioinformatics. 2011;27:1009–1010. doi: 10.1093/bioinformatics/btr039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Cury J, Jové T, Touchon M, Néron B, Rocha EP. Identification and analysis of integrons and cassette arrays in bacterial genomes. Nucleic Acids Res. 2016;44:4539–4550. doi: 10.1093/nar/gkw319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Koboldt DC, Larson DE, Wilson RK. Using VarScan 2 for germline variant calling and somatic mutation detection. Curr Protoc Bioinformatics. 2013;44:11–17. doi: 10.1002/0471250953.bi1504s44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res. 2015;43:e15. doi: 10.1093/nar/gku1196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol. 2012;19:455–477. doi: 10.1089/cmb.2012.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Johnson TJ, Danzeisen JL, Youmans B, Case K, Llop K, et al. Separate F-type plasmids have shaped the evolution of the H30 subclone of Escherichia coli sequence type 131. mSphere. 2016;1 doi: 10.1128/mSphere.00121-16. 29 06 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Suzuki H, Sota M, Brown CJ, Top EM. Using Mahalanobis distance to compare genomic signatures between bacterial plasmids and chromosomes. Nucleic Acids Res. 2008;36:e147. doi: 10.1093/nar/gkn753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13:e1005595. doi: 10.1371/journal.pcbi.1005595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Bergquist PL, Saadi S, Maas WK. Distribution of basic replicons having homology with RepFIA, RepFIB, and RepFIC among IncF group plasmids. Plasmid. 1986;15:19–34. doi: 10.1016/0147-619X(86)90011-9. [DOI] [PubMed] [Google Scholar]
  • 49.Sengupta M, Austin S. Prevalence and significance of plasmid maintenance functions in the virulence plasmids of pathogenic bacteria. Infect Immun. 2011;79:2502–2509. doi: 10.1128/IAI.00127-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Escudero JA, Loot C, Nivina A, Mazel D. The integron: adaptation on demand. Microbiol Spectr. 2015;3:MDNA3-0019-2014. doi: 10.1128/microbiolspec.MDNA3-0019-2014. [DOI] [PubMed] [Google Scholar]
  • 51.Cambray G, Guerout A-M, Mazel D. Integrons. Annu Rev Genet. 2010;44:141–166. doi: 10.1146/annurev-genet-102209-163504. [DOI] [PubMed] [Google Scholar]
  • 52.Boucher Y, Labbate M, Koenig JE, Stokes HW. Integrons: mobilizable platforms that promote genetic diversity in bacteria. Trends Microbiol. 2007;15:301–309. doi: 10.1016/j.tim.2007.05.004. [DOI] [PubMed] [Google Scholar]
  • 53.Paulsen IT, Littlejohn TG, Rådström P, Sundström L, Sköld O, et al. The 3' conserved segment of integrons contains a gene associated with multidrug resistance to antiseptics and disinfectants. Antimicrob Agents Chemother. 1993;37:761–768. doi: 10.1128/AAC.37.4.761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Labar AS, Millman JS, Ruebush E, Opintan JA, Bishar RA, et al. Regional dissemination of a trimethoprim-resistance gene cassette via a successful transposable element. PLoS One. 2012;7:e38142. doi: 10.1371/journal.pone.0038142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Adrian PV, Thomson CJ, Klugman KP, Amyes SG. New gene cassettes for trimethoprim resistance, dfr13, and Streptomycin-spectinomycin resistance, aadA4, inserted on a class 1 integron. Antimicrob Agents Chemother. 2000;44:355–361. doi: 10.1128/AAC.44.2.355-361.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Woodford N, Carattoli A, Karisik E, Underwood A, Ellington MJ, et al. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom. All Belonging to the International O25:H4-ST131 Clone. 2009;53:4472–4482. doi: 10.1128/AAC.00688-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Solberg OD, Ajiboye RM, Riley LW. Origin of class 1 and 2 integrons and gene cassettes in a population-based sample of uropathogenic Escherichia coli . J Clin Microbiol. 2006;44:1347–1351. doi: 10.1128/JCM.44.4.1347-1351.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Sundin GW, Bender CL. Dissemination of the strA-strB streptomycin-resistance genes among commensal and pathogenic bacteria from humans, animals, and plants. Mol Ecol. 1996;5:133–143. doi: 10.1111/j.1365-294X.1996.tb00299.x. [DOI] [PubMed] [Google Scholar]
  • 59.Boyd ES, Barkay T. The mercury resistance operon: from an origin in a geothermal environment to an efficient detoxification machine. Front Microbiol. 2012;3 doi: 10.3389/fmicb.2012.00349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Skurnik D, Ruimy R, Ready D, Ruppe E, Bernède-Bauduin C, et al. Is exposure to mercury a driving force for the carriage of antibiotic resistance genes? J Med Microbiol. 2010;59:804–807. doi: 10.1099/jmm.0.017665-0. [DOI] [PubMed] [Google Scholar]
  • 61.Reith ME, Singh RK, Curtis B, Boyd JM, Bouevitch A, et al. The genome of Aeromonas salmonicida subsp. salmonicida A449: insights into the evolution of a fish pathogen. BMC Genomics. 2008;9:427. doi: 10.1186/1471-2164-9-427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.He S, Chandler M, Varani AM, Hickman AB, Dekker JP, et al. Mechanisms of evolution in High-Consequence drug resistance plasmids. mBio. 2016;7:e01987–01916. doi: 10.1128/mBio.01987-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.He S, Hickman AB, Varani AM, Siguier P, Chandler M, et al. Insertion sequence IS26 reorganizes plasmids in clinically isolated multidrug-resistant bacteria by replicative transposition. mBio. 2015;6:e00762. doi: 10.1128/mBio.00762-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Harmer CJ, Moran RA, Hall RM. Movement of IS26-associated antibiotic resistance genes occurs via a translocatable unit that includes a single IS26 and preferentially inserts adjacent to another IS26. mBio. 2014;5:e01801–01814. doi: 10.1128/mBio.01801-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Livermore DM, Day M, Cleary P, Hopkins KL, Toleman MA, et al. Oxa-1 β-lactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBL-producing Escherichia coli. J Antimicrob Chemother. 2019;74:326–333. doi: 10.1093/jac/dky453. [DOI] [PubMed] [Google Scholar]
  • 66.Bergstrom CT, Lipsitch M, Levin BR. Natural selection, infectious transfer and the existence conditions for bacterial plasmids. Genetics. 2000;155:1505–1519. doi: 10.1093/genetics/155.4.1505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Porse A, Schønning K, Munck C, Sommer MOA. Survival and evolution of a large multidrug resistance plasmid in new clinical bacterial hosts. Mol Biol Evol. 2016;33:2860–2873. doi: 10.1093/molbev/msw163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Lawrence JG, Ochman H. Amelioration of bacterial genomes: rates of change and exchange. J Mol Evol. 1997;44:383–397. doi: 10.1007/PL00006158. [DOI] [PubMed] [Google Scholar]
  • 69.Carroll AC, Wong A. Plasmid persistence: costs, benefits, and the plasmid paradox. Can J Microbiol. 2018;64:293–304. doi: 10.1139/cjm-2017-0609. [DOI] [PubMed] [Google Scholar]
  • 70.Argudín MA, Hoefer A, Butaye P. Heavy metal resistance in bacteria from animals. Res Vet Sci. 2019;122:132–147. doi: 10.1016/j.rvsc.2018.11.007. [DOI] [PubMed] [Google Scholar]
  • 71.Hobman JL, Crossman LC. Bacterial antimicrobial metal ion resistance. J Med Microbiol. 2015;64:471–497. doi: 10.1099/jmm.0.023036-0. [DOI] [PubMed] [Google Scholar]
  • 72.MacLean RC, San Millan A. Microbial evolution: towards resolving the plasmid paradox. Curr Biol. 2015;25:R764–R767. doi: 10.1016/j.cub.2015.07.006. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material 1
Supplementary material 2

Articles from Microbial Genomics are provided here courtesy of Microbiology Society

RESOURCES